RCM

RA Capital Management Portfolio holdings

AUM $9.44B
1-Year Est. Return 157.3%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+157.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.44B
AUM Growth
-$323M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1
+$216M
2
+$114M
3
+$106M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$75.5M
5
NUVL icon
Nuvalent
NUVL
+$66.7M

Top Sells

1
+$743M
2
+$623M
3
+$82.6M
4
BLTE
Belite Bio
BLTE
+$69.2M
5
IVVD icon
Invivyd
IVVD
+$42.3M

Sector Composition

1 Healthcare 99.71%
2 Financials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYRE icon
26
Spyre Therapeutics
SYRE
$6.38B
$81.8M 0.87%
1,621,620
EVMN
27
Evommune Inc
EVMN
$837M
$80.3M 0.85%
3,494,638
+35,868
CLYM
28
Climb Bio
CLYM
$628M
$77.4M 0.82%
11,300,939
+7,111
SLDB icon
29
Solid Biosciences
SLDB
$723M
$67.2M 0.71%
9,339,978
+3,528,555
ARTV
30
Artiva Biotherapeutics
ARTV
$385M
$63.5M 0.67%
9,853,302
DMRA
31
Damora Therapeutics
DMRA
$1.53B
$62.1M 0.66%
+2,399,310
XNCR icon
32
Xencor
XNCR
$881M
$59.1M 0.63%
+4,897,237
LBRX
33
LB Pharmaceuticals
LBRX
$802M
$54.5M 0.58%
2,208,604
JBIO
34
Jade Biosciences
JBIO
$1.04B
$51.6M 0.55%
3,671,083
ABOS icon
35
Acumen Pharmaceuticals
ABOS
$188M
$49.5M 0.52%
20,992,669
+6,060,606
FDMT icon
36
4D Molecular Therapeutics
FDMT
$518M
$47M 0.5%
5,049,779
-603,432
FULC icon
37
Fulcrum Therapeutics
FULC
$461M
$46.4M 0.49%
6,053,960
CAPR icon
38
Capricor Therapeutics
CAPR
$1.74B
$45.8M 0.49%
1,507,844
IPSC icon
39
Century Therapeutics
IPSC
$442M
$40.1M 0.43%
+17,754,430
OLMA icon
40
Olema Pharmaceuticals
OLMA
$1.15B
$38.8M 0.41%
2,600,000
LENZ
41
LENZ Therapeutics
LENZ
$244M
$38.2M 0.41%
4,178,823
MNPR icon
42
Monopar Therapeutics
MNPR
$436M
$36.6M 0.39%
667,207
PEPG icon
43
PepGen
PEPG
$104M
$35.5M 0.38%
20,064,545
DSGN icon
44
Design Therapeutics
DSGN
$655M
$31.6M 0.34%
2,972,973
+1,511,592
MIRM icon
45
Mirum Pharmaceuticals
MIRM
$6.19B
$29.4M 0.31%
+318,554
BIOA
46
BioAge Labs
BIOA
$769M
$28.9M 0.31%
+1,650,648
LXEO icon
47
Lexeo Therapeutics
LXEO
$404M
$28.7M 0.3%
5,000,000
ASMB icon
48
Assembly Biosciences
ASMB
$548M
$28.3M 0.3%
1,020,410
RZLT icon
49
Rezolute
RZLT
$318M
$28M 0.3%
9,180,000
AKTS
50
Aktis Oncology
AKTS
$1.15B
$26.9M 0.28%
+1,503,084
1
2
3 4